Pfizer Chief Calls Patent Pool ‘Nonsense’, Fears Tussle Over Vaccine
Big Pharma Pledges No Profits During Pandemic, But Will Not Relinquish IP
Pharma will oppose a patent pool, but the world still needs a way to guarantee fair access to COVID-19 vaccines.
You may also be interested in...
Also, Neoimmune looks to interleukin therapy for mild therapy while Daiichi Sankyo bets on a mRNA vaccine.
An official announcement is expected within weeks, as competition between US and China stokes fears of 'vaccine nationalism'.
C-TAP, the voluntary initiative aimed at making vaccines, tests, treatments and other health technologies to fight COVID-19 accessible to all, has been launched by the WHO, in partnership with Costa Rica.